ClinicalTrials.Veeva

Menu

Smoking Relapse-Prevention Intervention for Cancer Patients

H. Lee Moffitt Cancer Center and Research Institute logo

H. Lee Moffitt Cancer Center and Research Institute

Status

Completed

Conditions

Smoking Cessation

Treatments

Behavioral: Smoking Relapse Prevention for Cancer Patients (SRP-CaP)
Behavioral: Usual Care

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01630161
5R01CA154596-02 (U.S. NIH Grant/Contract)
MCC-16458

Details and patient eligibility

About

The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.

Full description

This study involves participation at four distinct time points over a one-year period.

  • Baseline assessment
  • 2-month follow-up telephone call
  • 6-month follow-up telephone call
  • 12-month follow-up telephone call

Enrollment

441 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have smoked at least 10 cigarettes per day for at least one year prior to cancer diagnosis
  • Able to read and write English
  • Able to give informed consent
  • Have quit smoking after receiving their cancer diagnosis
  • Have not quit greater than 3 months prior

Exclusion criteria

  • Individuals who have been abstinent for greater than 3 months are not included because they are less likely to relapse. A quit will be defined as self-reported no smoking for 24 hours. Individuals with metastatic disease will be excluded because participation in the study might be burdensome.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

441 participants in 2 patient groups

Usual Care
Active Comparator group
Description:
Participants randomized to the Usual Care condition will receive standard care following recruitment.
Treatment:
Behavioral: Usual Care
Relapse-Prevention Intervention
Active Comparator group
Description:
Participants randomized to the Smoking Relapse Prevention for Cancer Patients (SRP-CaP) intervention will receive standard care plus our self-help smoking-relapse prevention materials.
Treatment:
Behavioral: Smoking Relapse Prevention for Cancer Patients (SRP-CaP)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems